
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
An in-house specialty pharmacy can provide significant financial gain for health systems by preventing revenue from being diverted to outside pharmacies.
Published: August 27th 2019 | Updated: